Benefit of Cilostazol in Patients with High Risk of Bleeding: Subanalysis of Cilostazol Stroke Prevention Study 2

Publisher： Karger

E-ISSN： 1421-9786|37|4|296-303

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.37, Iss.4, 2014-05, pp. : 296-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet Cilostazol Is Effective in the Prevention of Pneumonia in Ischemic Stroke Patients in the Chronic Stage

By  

Cerebrovascular Diseases, Vol. 22, Iss. 1, 2006-04 ,pp. : 57-60

Karger

Access to resources Recommend Favorite

Antiplatelet Cilostazol Is Beneficial in Diabetic and/or Hypertensive Ischemic Stroke Patients

By  

Cerebrovascular Diseases, Vol. 26, Iss. 1, 2008-05 ,pp. : 63-70

Karger

Access to resources Recommend Favorite

Ultra-Early Combination Antiplatelet Therapy with Cilostazol for the Prevention of Branch Atheromatous Disease: A Multicenter Prospective Study

By  

Cerebrovascular Diseases Extra, Vol. 6, Iss. 3, 2016-10 ,pp. : 84-95

Karger

Access to resources Recommend Favorite

New therapeutic effects of cilostazol in patients with ischemic disorders

By  

Current Vascular Pharmacology, Vol. 13, Iss. 3, 2015-05 ,pp. : 399-404

Bentham Science Publishers

Access to resources Recommend Favorite

Cilostazol Decreases Cerebral Arterial Pulsatility in Patients with Mild White Matter Hyperintensities: Subgroup Analysis from the Effect of Cilostazol in Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler (ECLIPse) Study

By  

Cerebrovascular Diseases, Vol. 38, Iss. 3, 2014-10 ,pp. : 197-203

Karger

Access to resources Recommend Favorite